KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Staar Surgical (STAA) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to -$843000.0.

  • Staar Surgical's Other Non Operating Income fell 11421.35% to -$843000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 15855.95%. This contributed to the annual value of -$3.7 million for FY2024, which is 9250.92% down from last year.
  • As of Q3 2025, Staar Surgical's Other Non Operating Income stood at -$843000.0, which was down 11421.35% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Other Non Operating Income ranged from a high of $5.9 million in Q3 2024 and a low of -$4.3 million during Q4 2024
  • Over the past 5 years, Staar Surgical's median Other Non Operating Income value was -$879000.0 (recorded in 2022), while the average stood at -$270150.0.
  • The largest annual percentage gain for Staar Surgical's Other Non Operating Income in the last 5 years was 52854.05% (2024), contrasted with its biggest fall of 374603.17% (2024).
  • Staar Surgical's Other Non Operating Income (Quarter) stood at -$924000.0 in 2021, then soared by 446.0% to $3.2 million in 2022, then tumbled by 58.37% to $1.3 million in 2023, then plummeted by 420.06% to -$4.3 million in 2024, then surged by 80.21% to -$843000.0 in 2025.
  • Its last three reported values are -$843000.0 in Q3 2025, $2.6 million for Q2 2025, and $1.4 million during Q1 2025.